Literature DB >> 23460121

[Bone marrow edema syndrome (BMES)].

B S Craiovan1, C Baier, J Grifka, J Götz, J Schaumburger, J Beckmann.   

Abstract

Bone marrow edema (BME) syndrome represents a pathologic accumulation of interstitial fluid in bone - with a traumatic BME being differentiated from a non-traumatic, often ischemic, and a reactive as well as a mechanical BME. Atraumatic/ischemic BME is inconsistently described as a separate entity or as a reversible preliminary stage of osteonecrosis (ON). However, there is always the risk of transformation of BME into ON and subsequent joint destruction. The most common sites of BME are the hip, knee, and ankle. Magnetic resonance imaging is the diagnostic gold standard. Differential diagnoses of the transient BME as osteonecrosis, osteochondrosis dissecans, and a reflex dystrophy should be considered. Conservative or surgical treatment is considered, depending on the etiology of BME. BME syndrome is generally treated conservatively. Infusion of prostacycline or bisphosphonates is a promising option. Ischemic BME and early stages of ON can be successfully treated by core decompression. A combination of both treatment options may also offer advantages.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23460121     DOI: 10.1007/s00132-012-2053-1

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  21 in total

1.  The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study.

Authors:  Kuo-An Lai; Wun-Jer Shen; Chyun-Yu Yang; Chung-Jung Shao; Jui-Ting Hsu; Ruey-Mo Lin
Journal:  J Bone Joint Surg Am       Date:  2005-10       Impact factor: 5.284

2.  Intravenous iloprost: a new therapeutic option for patients with post-transplant distal limb syndrome (PTDLS).

Authors:  F-P Tillmann; M Jäger; D Blondin; D Schooldermann; A Voiculescu; C Sucker; B Grabensee; R Krauspe; G R Hetzel
Journal:  Am J Transplant       Date:  2007-01-11       Impact factor: 8.086

Review 3.  Distinguishing transient osteoporosis from avascular necrosis of the hip.

Authors:  J J Guerra; M E Steinberg
Journal:  J Bone Joint Surg Am       Date:  1995-04       Impact factor: 5.284

4.  Bone marrow edema syndrome of the femoral head: treatment with the prostacyclin analogue iloprost vs. core decompression: an MRI-controlled study.

Authors:  Nicolas Aigner; Gert Petje; Wolfgang Schneider; Roland Meizer; Matthias Wlk; Spyridon Kotsaris; Karl Knahr; Franz Landsiedl
Journal:  Wien Klin Wochenschr       Date:  2005-02       Impact factor: 1.704

Review 5.  [Imaging of avascular necrosis of the femoral head in adults].

Authors:  S Reppenhagen; W Kenn; J Reichert; P Raab; J Eulert; U Nöth
Journal:  Orthopade       Date:  2007-05       Impact factor: 1.087

Review 6.  [Femoral head necrosis].

Authors:  J Kramer; G Scheurecker; A Scheurecker; A Stöger; A Huber; S Hofmann
Journal:  Radiologe       Date:  2009-05       Impact factor: 0.635

7.  Bone marrow edema syndrome in postpartal women: treatment with iloprost.

Authors:  Nicholas Aigner; Roland Meizer; Dominik Meraner; Stephan Becker; Elizabeth Meizer; Franz Landsiedl
Journal:  Orthop Clin North Am       Date:  2009-04       Impact factor: 2.472

Review 8.  Bone marrow edema syndrome.

Authors:  Anastasios V Korompilias; Apostolos H Karantanas; Marios G Lykissas; Alexandros E Beris
Journal:  Skeletal Radiol       Date:  2008-07-16       Impact factor: 2.199

Review 9.  Histopathological perspective on bone marrow oedema, reactive bone change and haemorrhage.

Authors:  W A Thiryayi; S A Thiryayi; A J Freemont
Journal:  Eur J Radiol       Date:  2008-03-12       Impact factor: 3.528

10.  Infusion, core decompression, or infusion following core decompression in the treatment of bone edema syndrome and early avascular osteonecrosis of the femoral head.

Authors:  Johannes Beckmann; Thorsten Schmidt; Jens Schaumburger; Björn Rath; Christian Lüring; Markus Tingart; Joachim Grifka
Journal:  Rheumatol Int       Date:  2012-12-23       Impact factor: 2.631

View more
  2 in total

1.  [Recurrent migratory knee pain].

Authors:  V Reimer; A Ehrhardt; T Freitag; M Beer; S A Schmidt
Journal:  Radiologe       Date:  2015-12       Impact factor: 0.635

2.  Effects of intravenous iloprost therapy in patients with bone marrow oedema of the foot and ankle.

Authors:  Eric Röhner; Timo Zippelius; David Steindl; Jasmin Fussi; Carsten Perka
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-09-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.